Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced data from a post hoc analysis of the GALE extension study ...
Trattler: Patients with severe dry eye can in some cases be exceptionally challenging, and it can feel as if therapies are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback